Actionable news
All posts from Actionable news
Actionable news in AMGN: Amgen Inc.,

Carter Worth And Mike Khouw's Amgen Trade

Carter Worth And Mike Khouw's Amgen Trade - Amgen Inc. NASDAQ:AMGN, iShares NASDAQ Biotechnology Index Fund NASDAQ:IBB

He said that the stock consistently outperformed iShares NASDAQ Biotechnology Index (ETF) IBB, which is in his opinion a basis for a bullish setup. Worth believes the stock is going to break out on the upside and reach its highs at $181.

Related Link: Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences

Mike Khouw thinks the best way to make a bullish bet is by selling the October 165 put for $6.70. The trade starts to lose money below $158.30, or 4.45 percent lower from the current stock price. If Amgen stays above $165 at the October expiration, Khouw is going to collect 4 percent in three months.

Did you like this article? Could it have been improved? Please email with the story link to let us know!

© 2016 Benzinga does not provide investment advice. All rights reserved.